Wednesday, June 15, 2016 1:29:24 PM
If you're assuming ITD becomes absorbed into Kallo Inc or becomes a subsidiary of Kallo then you have that idea twisted and inside out. If anything similar to that would happen it would be ITD goes public with their own ticker and makes Kallo a subsidiary of them, BUT, THAT WON'T HAPPEN, AND HERE'S WHY:
1. ITD would in no way hire the Kallo leadership, when they have the financial means to hire ACTUAL successful vigilant leaders who actually have a proven track record of being successful and executing projects within the specific medical field. Not weak ass cecil and his team of no hitters.
2. ITD has the financial resources and success to sit at the table with the 'big boys' on their own reputation alone and be taken seriously by prospective clients.
3. Most importantly they wouldn't want to inherit Kallo's debt, however small it is, because there is no incentive that outweighs it, especially when ITD can hire a team of vigilant leaders who know how to close deals and execute for less than the current debt. It's a no brainer IMO.
4. Nothing to gain by maintaining a partnership with the Kallos weak, unsuccessful team.
In the end, no matter what happens with ITD, it won't hurt, or benefit KALO shareholders.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM